A proposed PBS crackdown on GLP-1 receptor agonists is inconsistent with type 2 diabetes management guidelines and will force doctors to prescribe less efficacious drugs,…
SGLT-2 inhibitors can cut the rate of recurrent gout flares by a third compared with DPP-4 inhibitors in older adults with type 2 diabetes, suggest…
Novo Nordisk has applied for PBS funding for its subcutaneous weight loss drug Wegovy as a severe obesity treatment. The product contains the GLP-1 receptor…
GPs are being advised to ration emergency glucagon kits and identify patients with type 1 diabetes with existing prescriptions in the wake of a critical…
Jamilla, 41, presents to hospital with epigastric pain, nausea and vomiting on a background of type 1 diabetes, diagnosed 11 years ago. During admission, she…
The high uptake of subsidised continuous glucose monitors shows the system is working in spite of a ban on GPs signing off the paperwork, says…
The TGA will allow pharmacists to swap out certain pre-filled insulin products in response to a global shortage predicted to last until June 2024. Ryzodeg…
The ban on GPs approving access to continuous glucose monitors under the National Diabetes Services Scheme has made them inaccessible for vulnerable patients, the RACGP…
GPs can now prescribe finerenone under the PBS to prevent worsening kidney function in adults with chronic kidney disease caused by type 2 diabetes. More…
Semaglutide could remain in short supply until the end of the year despite increased stock, the TGA has warned, amid concerns a rise in off-label…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
